Resultados de Búsqueda

Too Much Medicine - theBMJ [Demasiada Medicina-TheBMJ]

Wise J. BMJ 2017;358:j4171

The researchers analysed follow-up data from the West of Scotland Coronary Prevention Study (WOSCOPS)—a five year study in 1995 that provided the first evidence that treating men with high LDL levels with statins significantly reduced the risk of death from heart disease. For further information please visit the website of the initiative (link below)

Too Much Medicine - theBMJ [Demasiada Medicina-TheBMJ]

Iacobucci G. BMJ 2017;358:j4177

UK researchers estimated that one in five people attending general hospital clinics has abnormal health anxiety, exacerbated by researching symptoms online. For further information please visit the website of the initiative (link below)

Too Much Medicine - theBMJ [Demasiada Medicina-TheBMJ]

Mayor S. BMJ 2017;359:j5374

Shoulder pain accounts for more than 2% of all primary care consultations in the UK, and more than two thirds of these cases involve subacromial pain. Arthroscopic decompression surgery is commonly used to treat this type of shoulder pain on the basis that removing bone spurs and soft tissue that narrow the subacromial space will reduce pain caused by arm movement. But its effectiveness is not clear. For further information please visit the website of the initiative (link below)

Too Much Medicine - theBMJ [Demasiada Medicina-TheBMJ]

Mayor S. BMJ 2017;356:j869

Researchers analysed the association between a range of medical and psychosocial factors and LDL cholesterol levels in 1095 consecutive patients admitted to two hospitals in Norway with a myocardial infarction and/or for a coronary revascularisation procedure. They collected data from hospital records, a comprehensive questionnaire, clinical examinations, and blood samples, two to 36 months after admission.

Too Much Medicine - theBMJ [Demasiada Medicina-TheBMJ]

Wise J. BMJ 2017;356:j772

The online survey of 928 GPs in England, Northern Ireland, and Wales found that only half (51.7%) knew that tamoxifen can reduce breast cancer risk and that only a quarter were aware of the NICE guideline. The GPs were then informed about the NICE guidance, the eligibility criteria for tamoxifen, and the drug’s harms, benefits, and licensing status. They were also given one of four vignettes describing a hypothetical patient at increased risk of breast cancer.